Related references
Note: Only part of the references are listed.The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol
Bent H. Hellum et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells
Hye Hyun Yoo et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content
M. Modarai et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes
Bent H. Hellum et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers
Shinya Uchida et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats
C. Y. Yang et al.
FOOD AND CHEMICAL TOXICOLOGY (2006)
In vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: A recommendation for probe substrates
J Rautio et al.
DRUG METABOLISM AND DISPOSITION (2006)
Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein
JP Keogh et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Flavonoid-drug interactions: Effects of flavonoids on ABC transporters
ME Morris et al.
LIFE SCIENCES (2006)
MDR- and CYMA4-mediated drug-herbal interactions
D Pal et al.
LIFE SCIENCES (2006)
Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans
J Grenier et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics
J Rengelshausen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome p450 3A4, 2D6, and 2C9
SH Yale et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2005)
Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator
H Tuvesson et al.
DRUG METABOLISM AND DISPOSITION (2005)
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450IA2, 2D6, 2E1, and 3A4/5 phenotypes
BJ Gurley et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly - St John's wort, garlic oil, Panax ginseng and Ginkgo biloba
BJ Gurley et al.
DRUGS & AGING (2005)
Herb-drug interactions - A literature review
ZP Hu et al.
DRUGS (2005)
Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures
BJ Komoroski et al.
DRUG METABOLISM AND DISPOSITION (2004)
An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies
J Strandell et al.
PHYTOMEDICINE (2004)
Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers
JL Donovan et al.
DRUG METABOLISM AND DISPOSITION (2004)
Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers
R Ding et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo
JC Gorski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract
C Gaudineau et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Herbal modulation of P-glycoprotein
SF Zhou et al.
DRUG METABOLISM REVIEWS (2004)
In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes:: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto
BJ Gurley et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme
JS Markowitz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Bioavailability of β-aescin from horse chestnut seed extract:: Comparative clinical studies of two galenic formulations
D Bässler et al.
ADVANCES IN THERAPY (2003)
Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells
SZ Zhang et al.
PHARMACEUTICAL RESEARCH (2003)
Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice
ML Veronese et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
AH Schinkel et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Coordinate induction of both cytochrome P4503A and MDRI by St John's wort in healthy subjects
GK Dresser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Interactions of herbs with cytochrome P450
SF Zhou et al.
DRUG METABOLISM REVIEWS (2003)
Evidence for a non-MDR1 component in digoxin secretion by human intestinal Caco-2 epithelial layers
S Lowes et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Role of P-glycoprotein in pharmacokinetics - Clinical implications
JH Lin et al.
CLINICAL PHARMACOKINETICS (2003)
Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations
S Kressmann et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein
K Yasuda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: The role of gut CYP3A and P-glycoprotein
MP Di Marco et al.
LIFE SCIENCES (2002)
Effect of St John's wort on the pharmacokinetics of fexofenadine
ZQ Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro
VA Eagling et al.
XENOBIOTICA (2002)
Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19
JH Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Liquid chromatography/atmospheric pressure chemical ionization mass spectrometry of terpene lactones in plasma of volunteers dosed with Ginkgo biloba L. extracts
P Mauri et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2001)
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
D Dürr et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures
JW Budzinski et al.
PHYTOMEDICINE (2000)
Share Paper
